Drug Profile
Research programme: hearing loss therapeutics - Sanofi / Audion Therapeutics
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Audion Therapeutics; Sanofi
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Sensorineural hearing loss
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Sensorineural hearing loss in Netherlands
- 16 Jun 2011 Early research in Sensorineural hearing loss in Netherlands (unspecified route)